MOESM2 of Lipid levels, insulin resistance and cardiovascular risk over 96 weeks of antiretroviral therapy: a randomised controlled trial comparing low-dose stavudine and tenofovir

Additional file 2: Table S2. Title: Estimated means with 95% confidence intervals per outcome. Description of data: This table presents estimates of the means for each treatment group at 4 follow-up measurements based on a linear mixed model with correction for age, sex, site of inclusion (South-Africa, Uganda or India), body mass index and viral load at baseline (see “Methods” for details)